CH290145A - Process for the preparation of sulfuric acid esters of xylan. - Google Patents
Process for the preparation of sulfuric acid esters of xylan.Info
- Publication number
- CH290145A CH290145A CH290145DA CH290145A CH 290145 A CH290145 A CH 290145A CH 290145D A CH290145D A CH 290145DA CH 290145 A CH290145 A CH 290145A
- Authority
- CH
- Switzerland
- Prior art keywords
- xylan
- sulfuric acid
- preparation
- acid esters
- degree
- Prior art date
Links
- 229920001221 xylan Polymers 0.000 title claims description 12
- 150000004823 xylans Chemical class 0.000 title claims description 12
- 238000000034 method Methods 0.000 title claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical class OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 title claims description 4
- 238000002360 preparation method Methods 0.000 title description 4
- 238000006116 polymerization reaction Methods 0.000 claims description 7
- 230000002429 anti-coagulating effect Effects 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 230000015556 catabolic process Effects 0.000 claims description 4
- 238000006731 degradation reaction Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 238000000338 in vitro Methods 0.000 claims description 3
- 238000001727 in vivo Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 2
- UFWWAKOWSBGGCP-UHFFFAOYSA-N pyridine;sulfurochloridic acid Chemical compound OS(Cl)(=O)=O.C1=CC=NC=C1 UFWWAKOWSBGGCP-UHFFFAOYSA-N 0.000 claims description 2
- -1 sulfuric acid ester Chemical class 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 239000000047 product Substances 0.000 description 12
- 238000005987 sulfurization reaction Methods 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000015271 coagulation Effects 0.000 description 6
- 238000005345 coagulation Methods 0.000 description 6
- 239000007795 chemical reaction product Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- KEQGZUUPPQEDPF-UHFFFAOYSA-N 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC1(C)N(Cl)C(=O)N(Cl)C1=O KEQGZUUPPQEDPF-UHFFFAOYSA-N 0.000 description 1
- JTNCEQNHURODLX-UHFFFAOYSA-N 2-phenylethanimidamide Chemical compound NC(=N)CC1=CC=CC=C1 JTNCEQNHURODLX-UHFFFAOYSA-N 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 240000000731 Fagus sylvatica Species 0.000 description 1
- 235000010099 Fagus sylvatica Nutrition 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 159000000009 barium salts Chemical class 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- XTHPWXDJESJLNJ-UHFFFAOYSA-N chlorosulfonic acid Substances OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 239000011121 hardwood Substances 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229910000343 potassium bisulfate Inorganic materials 0.000 description 1
- DJEHXEMURTVAOE-UHFFFAOYSA-M potassium bisulfite Chemical compound [K+].OS([O-])=O DJEHXEMURTVAOE-UHFFFAOYSA-M 0.000 description 1
- 229940099427 potassium bisulfite Drugs 0.000 description 1
- 235000010259 potassium hydrogen sulphite Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000004552 water soluble powder Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0057—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Xylans, i.e. xylosaccharide, e.g. arabinoxylan, arabinofuronan, pentosans; (beta-1,3)(beta-1,4)-D-Xylans, e.g. rhodymenans; Hemicellulose; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Description
Verfahren zur Herstellung von Schwefelsäureestern des Xylans.
Es ist bekannt, dass bei der Sulfurierung von polymeren Hexosen (nämlich Cellulose, Stärke, Glykogen, Pektin und Chitin) mit Chlorsulfonsäure-Pyridin-Gemisch Reaktionsprodukte entstehen, die je nach Wahl des Ausgangsproduktes imstande sind, die natürliebe Gerinnbarkeit des Blutes zu verzögern oder ganz aufzuheben.
Sulfurierungsprodukte der Pentosane, zum Beispiel des Xylans, sind bisher nicht be kannt. Es war auch nicht vorauszusehen, dass Sulfurieruiigsprodukte der Pentosane die Blutgerinnung in heparinähnlicher Weise verzögern oder aufheben.
Es wurde nun gefunden, dass bei der Sulfurierung von Pentosanen unter verschiedenen Bedingungen Reaktionsprodukte entstehen, welche blutgerinnungshemmende Wirkung besitzen. Ferner wurde gefunden, dass das Mass der blutgerinnungshemmenden Wir kung abhängig ist von den Bedingungen, unter denen die Sulfurierung durchgeführt wird.
.Te nach den Vorbedingungen entstehen Produkte mit verschiedener Viskosität, woraus zu schliessen ist, dass sie versehiedeneMolekular- grössen besitzen. Es findet während der Sulfurierung ein teilweiser Abbau der Pentosan Moleküle, also eine teilweise Entpolymerisierung, statt. Derselbe Vorgang kann auch erzielt werden durch Vorbehandlung der Pentosane vor der eigentlichen Sulfurierung. In gewissem Ausmasse ist die hlutgerinnungs- hemmende Wirkung abhängig von der Viskosi tät und damit von der Molekulargrösse. Das Optimum der blutgerinnungshemmenden Wir kung liegt bei einem Polymerisationsgrad von
10 bis 100, vorzugsweise 20 bis 80.
Dies kann entweder durch Steuerung der Sulfurierung oder durch Abbau vor der Sulfurierung ge schehen.
Gegenstand des Patentes ist nun ein Ver fahren zur Herstellung eines Sehwefelsäure- esters von teilweise abgebautem Xylan, wel ches dadurch gekennzeichnet ist, dass man, ausgehend von Xylan, einerseits einen Abbau und anderseits eine ISulfierung vornimmt, und zwar derart, dass das erhaltene Produkt einen
Polymerisationsgrad zwischen 10 und 100 auf weist.
Das so erhaltene Sulfurierungsprodukt ist ein amorphes, leicht wasserlösliches, in Alko hol unlösliches Pulver. Es bildet neutral rea gierende Alkalisalze, die in Wasser leicht löslich sind. Die Bariumsalze sind schwer lös lich. Die wässerigen Lösungen sind koch- und lichtbeständig. Das Produkt ist imstande, in vitro ebenso wie in vivo die Gerinnung des natürlichen Blutes (Säugetierblut oder Men sehenblut) zu verzögern oder ganz aufzu heben.
1. Prüfung in vitro:
In einer Rekordspritze, die mit 0,2 cm3
3, 8prozentiger Natriumzitratlösung beschickt ist, wird 0,8 cm3 Blut aufgezogen und gut ge mischt. Von diesem Gemisch werden 0,1 ems in ein kleines Reagensgläschen gegeben; dazu kommen 0,2 cm3 aqu.dest., in dem die zu prüfende Substanz gelöst ist. Einhängen in ein Wasserbad von 37 für eine Minute. Es wird eine 0, 5prozentige, genau eingestellte Calcium ehloridlösung eingeblasen und die Zeit vom Beginn des Einblasens an bis zum Auftreten der Gerinnung gemessen. Drei Einzelproben geben einen Wert.
Ein Präparat mit einem sp/e-Wert von 0,015 verlängert die menschliche Blutgerin nungszeit von 2'35" bei einer Konzentration von 5 y pro cm3 auf 7'43", bei 2,5 y auf 6'15". Bei einer Beobachtungszeit von 2 Stunden bei einer Konzentration von 25 y pro cm Blut tritt keine Gerinnung ein.
2. Prüfqbng in vivo:
Einem Kaninchen werden 3 mg pro kg intravenös injiziert und nach Bestimmung des Normalgerinnungswertes das Blut 5 Minuten nach der Injektion und dann in halb stündigem Abstand entnommen.
Ein Präparat mit einem Ssplc-Wert von 0,015 verlängert 4 Stunden nach der Injektion die Blutgerinnungszeit noch um das Doppelte.
Beispiele:
1. 3 g frisch umgefälltes Xylan, das durch Extrahieren von Laubholzmehl (insbesondere Buchen- oder Birkenholz) mit 8prozentiger Natronlauge gewonnen wurde (Husemann, Journal f. prakt. Chemie 155, 38; 1940) werden mit einem Gemisch von 60 cm3 Pyridin und 14 cm3 Chlorsulfonsäure unter Rühren 8 Stunden auf 100O erhitzt und nach dem Abkühlen in 1 Liter Methanol eingegossen.
Nach dem Auswasehen wird mit wenig Wasser gelöst, zentrifugiert, mit 8prozentiger Natronlauge behandelt und durch Eingiessen in das 10faehe Volumen Methanol ausgefällt.
Weitere Reinigung durch Dialyse.
Das gewonnene Produkt weist einen Poly mcrisationsgrad von etwa 50 auf.
2. Xylan wird vor der Veresterung durch Erhitzung mit 0,5n-Kaliumbisulfat oder einer Säure (zum Beispiel Salzsäure) teilweise depolymerisiert. Dieses Reaktionsprodukt wird, wie in Beispiel 1, jedoch bei einer Temperatur von 600 verestert. Der Abbaugrad wird durch Kontrolle der dsple-Werte verfolgt. Der dsple-Wert des fertig sulfurierten Produktes ist etwa halb so gross wie der des ursprüngliehen Xylans. Durch bestimmte Leitung des Abbaues wird das Optimum an Wirkung bei guter Ausbeute erzielt.
Der Polymerisationsgrad des fertigen Produktes lässt sich durch die Dauer der vor der Sulfurierung vorgenommenen Erhitzung mit Waliumbisulfit oder Säure stark beeinflussen. Bei 24stündigem Erhitzen eines Xylans mit dem ungefähren Polymerisationsgrad 150 in 0,5n-Kaliumbisulfit lag zum Beispiel der Polymerisationsgrad des fertig sulfurierten Produktes bei ungefähr 30. Bei einem 2 bis 3 Tage dauernden, sonst genau auf gleiche Weise vorgenommenen Abbau des Xylans vor der Veresterung wurden sulfurierte Produkte mit einem Polymerisationsgrad um 20 herum erhalten.
Process for the preparation of sulfuric acid esters of xylan.
It is known that the sulphuration of polymeric hexoses (namely cellulose, starch, glycogen, pectin and chitin) with a chlorosulphonic acid-pyridine mixture results in reaction products which, depending on the choice of the starting product, are able to delay the natural coagulability of the blood or entirely cancel.
Sulfuration products of pentosans, for example xylan, are not yet known. Nor could it be foreseen that sulfurous products of the pentosans would delay or abolish blood clotting in a manner similar to that of heparin.
It has now been found that the sulfurization of pentosans under various conditions gives rise to reaction products which have an anti-coagulant effect. It has also been found that the extent of the anticoagulant effect depends on the conditions under which the sulfurization is carried out.
Depending on the preconditions, products with different viscosities arise, from which it can be concluded that they have different molecular sizes. During the sulfurization, the pentosan molecules are partially broken down, i.e. partial depolymerization. The same process can also be achieved by pretreating the pentosans before the actual sulfurization. To a certain extent, the anticoagulant effect depends on the viscosity and thus on the molecular size. The optimum anticoagulant effect is at a degree of polymerization of
10 to 100, preferably 20 to 80.
This can be done either by controlling sulfurization or by pre-sulfurization mining.
The subject of the patent is now a process for the production of a sulfuric acid ester of partially degraded xylan, wel ches is characterized in that starting from xylan, on the one hand a degradation and on the other hand an ISulfierung carried out, in such a way that the product obtained a
Degree of polymerization between 10 and 100 has.
The sulfurization product obtained in this way is an amorphous, readily water-soluble powder which is insoluble in alcohol. It forms neutrally reacting alkali salts which are easily soluble in water. The barium salts are sparingly soluble. The aqueous solutions are resistant to boiling and light. The product is able to delay or completely stop the coagulation of natural blood (mammalian blood or men’s blood) in vitro as well as in vivo.
1. In vitro test:
In a record syringe with 0.2 cm3
3.8 percent sodium citrate solution is charged, 0.8 cm3 of blood is drawn up and mixed well. 0.1 ems of this mixture is placed in a small test tube; 0.2 cm3 distilled water are added in which the substance to be tested is dissolved. Hang in a 37 water bath for one minute. A 0.5 percent, precisely adjusted calcium chloride solution is blown in and the time from the beginning of the blowing in to the occurrence of coagulation is measured. Three individual samples give a value.
A preparation with an sp / e value of 0.015 extends the human coagulation time from 2'35 "at a concentration of 5 y per cm3 to 7'43", at 2.5 y to 6'15 " No coagulation occurs for 2 hours at a concentration of 25 μg per cm of blood.
2. In vivo test:
A rabbit is injected intravenously with 3 mg per kg and, after the normal coagulation value has been determined, the blood is taken 5 minutes after the injection and then every half an hour.
A preparation with an Ssplc value of 0.015 doubles the coagulation time 4 hours after the injection.
Examples:
1. 3 g of freshly reprecipitated xylan, which was obtained by extracting hardwood flour (in particular beech or birch wood) with 8 percent sodium hydroxide solution (Husemann, Journal f. Pract. Chemie 155, 38; 1940), are mixed with a mixture of 60 cm3 of pyridine and 14 cm3 of chlorosulfonic acid heated to 100 ° for 8 hours while stirring and, after cooling, poured into 1 liter of methanol.
After washing out, it is dissolved with a little water, centrifuged, treated with 8 percent sodium hydroxide solution and precipitated by pouring into the 10-fold volume of methanol.
Further purification by dialysis.
The product obtained has a degree of polymerization of about 50.
2. Before esterification, xylan is partially depolymerized by heating with 0.5N potassium bisulfate or an acid (for example hydrochloric acid). This reaction product is esterified as in Example 1, but at a temperature of 600. The degree of degradation is monitored by checking the dsple values. The dsple value of the finished sulfurized product is about half as large as that of the original xylan. By directing the degradation in a certain way, the optimum effect is achieved with good yield.
The degree of polymerisation of the finished product can be greatly influenced by the duration of the heating with walium bisulphite or acid before sulphurisation. For example, when a xylan with an approximate degree of polymerization of 150 was heated in 0.5N potassium bisulfite for 24 hours, the degree of polymerization of the finished sulfurized product was approximately 30. When the xylan was broken down in exactly the same way for 2 to 3 days before esterification sulfurized products with a degree of polymerization around 20 are obtained.
Claims (1)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE290145X | 1944-06-13 | ||
| DE311219X | 1944-07-10 | ||
| DE289738X | 1949-11-07 | ||
| DE21150X | 1950-11-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH290145A true CH290145A (en) | 1953-04-15 |
Family
ID=27430301
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH290145D CH290145A (en) | 1944-06-13 | 1951-07-23 | Process for the preparation of sulfuric acid esters of xylan. |
Country Status (1)
| Country | Link |
|---|---|
| CH (1) | CH290145A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2543145A1 (en) * | 1983-03-24 | 1984-09-28 | Sanofi Sa | NOVEL XYLANES SULFATES, PROCESS FOR PREPARING THEM AND ANTI-THROMBOTIC AND HYPOLIPEMIANT ACTIVITY |
| WO2008107906A1 (en) * | 2007-03-06 | 2008-09-12 | Alembic Limited | Process for the preparation of pentosan polysulfate or salts thereof |
| WO2009047699A1 (en) * | 2007-10-10 | 2009-04-16 | Alembic Limited | An improved process for the preparation of an amorphous form of pentosan polysulfate or salts thereof |
| DE102020101915A1 (en) | 2020-01-28 | 2021-07-29 | Holger Wondraczek | Process for extracting xylan compounds from crushed wood components |
-
1951
- 1951-07-23 CH CH290145D patent/CH290145A/en unknown
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2543145A1 (en) * | 1983-03-24 | 1984-09-28 | Sanofi Sa | NOVEL XYLANES SULFATES, PROCESS FOR PREPARING THEM AND ANTI-THROMBOTIC AND HYPOLIPEMIANT ACTIVITY |
| EP0125152A1 (en) * | 1983-03-24 | 1984-11-14 | Sanofi | Sulphated xylanes, process for their preparation and their antithrombotic and hypolipemic activity |
| WO2008107906A1 (en) * | 2007-03-06 | 2008-09-12 | Alembic Limited | Process for the preparation of pentosan polysulfate or salts thereof |
| WO2009047699A1 (en) * | 2007-10-10 | 2009-04-16 | Alembic Limited | An improved process for the preparation of an amorphous form of pentosan polysulfate or salts thereof |
| DE102020101915A1 (en) | 2020-01-28 | 2021-07-29 | Holger Wondraczek | Process for extracting xylan compounds from crushed wood components |
| WO2021151656A1 (en) | 2020-01-28 | 2021-08-05 | Wondraczek Holger | Method for extracting xylan compounds from comminuted wood components |
| US12522672B2 (en) | 2020-01-28 | 2026-01-13 | HV-Polysaccharides GmbH & Co. KG | Method for extracting xylan compounds from comminuted wood components |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2154277C2 (en) | ||
| EP0113824B1 (en) | Waterinsoluble fibres from cellulose acetate, cellulose propionate and cellulose butyrate with a very high absorption capacity for water and physiological fluids, and process for their preparation | |
| CH290145A (en) | Process for the preparation of sulfuric acid esters of xylan. | |
| DE1668542A1 (en) | Process for the production of sulfuric acid esters from cellulose and starch | |
| DE516461C (en) | Process for the production of cellulose derivatives | |
| DE898947C (en) | Process for the production of artificial threads from peanut globulin | |
| US1082490A (en) | Process for preparing solutions of cellulose and for the production of cellulose products from such solutions. | |
| DE851947C (en) | Process for the production of cyanaethyl ethers of cellulose | |
| DE363997C (en) | Process for the production of high percentage sulphite pulp | |
| DE512160C (en) | Process for the production of threads or films from solutions of ethers and esters of cellulose | |
| DE498157C (en) | Process for the production of artificial structures, especially rayon | |
| DE636868C (en) | Process for the production of cellulose esters | |
| DE831096C (en) | Process for the production of sulfuric acid esters | |
| DE522575C (en) | Process for the production of cellulose ethers | |
| DE519138C (en) | Process for the production of novel cellulose derivatives | |
| DE578706C (en) | Process for the esterification of cellulose | |
| DE861241C (en) | Process for the production of water-soluble starch derivatives | |
| DE935843C (en) | Process for the preparation of an anti-coagulant | |
| DE807093C (en) | Process for acetylating raw pulp | |
| DE542868C (en) | Process for the preparation of cellulose acetobutyrates | |
| DE806994C (en) | Process for the preparation of an anti-coagulant | |
| DE393803C (en) | Process for the production of synthetic wool from cellulose | |
| DE545500C (en) | Pretreatment of cellulose for conversion into cellulose derivatives or cellulose solutions | |
| DE682591C (en) | Process for the production of water-soluble substances from lignin-containing material | |
| DE1792227C (en) | Process for converting unbleached sulphite pulp into an esterification-pure pulp |